logo
logo

Elixirgen Therapeutics announced it raised $5 Million in an initial filing from an offering of $5 Million

Sep 29, 2022•almost 3 years ago

Amount Raised

$5 Million

BaltimoreBiotechnology

Company Information

Company

Elixirgen Therapeutics

Location

855 N. WOLFE ST.

Baltimore, Maryland, United States

About

Elixirgen Therapeutics is a biotechnology company advancing its controllable self-replicating RNA technology to develop therapies for a broad spectrum of diseases, including rare diseases, aging-related disorders, and cancer. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore.

Related People